Di H, Rong Z, Mao N, Li H, Chen J, Liu R
BMC Cancer. 2025; 25(1):94.
PMID: 39819515
PMC: 11737189.
DOI: 10.1186/s12885-025-13476-7.
Liu Z, Lin H, Li X, Xue H, Lu Y, Xu F
Brief Bioinform. 2025; 26(1).
PMID: 39757115
PMC: 11700662.
DOI: 10.1093/bib/bbae698.
Smiriglia A, Lorito N, Serra M, Perra A, Morandi A, Kowalik M
iScience. 2023; 26(12):108363.
PMID: 38034347
PMC: 10682354.
DOI: 10.1016/j.isci.2023.108363.
Chelleri C, Scala M, De Marco P, Traverso M, Ognibene M, Bruno I
Front Pediatr. 2023; 11:1051026.
PMID: 36923276
PMC: 10010568.
DOI: 10.3389/fped.2023.1051026.
Zhang J, Li H, Dong J, Zhang N, Liu Y, Luo X
Front Genet. 2021; 12:620594.
PMID: 34135934
PMC: 8202007.
DOI: 10.3389/fgene.2021.620594.
Ras Signaling in Breast Cancer.
Moon A
Adv Exp Med Biol. 2021; 1187:81-101.
PMID: 33983574
DOI: 10.1007/978-981-32-9620-6_4.
Antitumor Activity of Extract on Oral Cancer: An In Vivo Study.
Al-Koshab M, Alabsi A, Bakri M, Ali-Saeed R, Naicker M
J Oncol. 2020; 2020:5490468.
PMID: 32104177
PMC: 7035569.
DOI: 10.1155/2020/5490468.
Tumor suppressive role of rottlerin in cancer therapy.
Ma J, Hou Y, Xia J, Zhu X, Wang Z
Am J Transl Res. 2019; 10(11):3345-3356.
PMID: 30662591
PMC: 6291697.
Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
Fan T, Rong Z, Dong J, Li J, Wang K, Wang X
Cancer Med. 2017; 6(10):2370-2384.
PMID: 28941178
PMC: 5633588.
DOI: 10.1002/cam4.1177.
Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.
Rong Z, Fan T, Li H, Li J, Wang K, Wang X
Mol Cell Proteomics. 2017; 16(8):1475-1490.
PMID: 28512230
PMC: 5546199.
DOI: 10.1074/mcp.M116.065474.
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.
Guerra E, Cimadamore A, Simeone P, Vacca G, Lattanzio R, Botti G
BMC Cancer. 2016; 16:649.
PMID: 27538498
PMC: 4991058.
DOI: 10.1186/s12885-016-2713-3.
Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
Yeh C, Chen P, Hsieh H, Jou Y, Lin C, Tsai M
Oncotarget. 2015; 6(30):29555-72.
PMID: 26320192
PMC: 4745746.
DOI: 10.18632/oncotarget.4986.
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).
Lassman A, Pugh S, Gilbert M, Aldape K, Geinoz S, Beumer J
Neuro Oncol. 2015; 17(7):992-8.
PMID: 25758746
PMC: 5762006.
DOI: 10.1093/neuonc/nov011.
Shikonin causes cell-cycle arrest and induces apoptosis by regulating the EGFR-NF-κB signalling pathway in human epidermoid carcinoma A431 cells.
Tian R, Li Y, Gao M
Biosci Rep. 2015; 35(2).
PMID: 25720435
PMC: 4413019.
DOI: 10.1042/BSR20150002.
Free fatty acids shift insulin-induced hepatocyte proliferation towards CD95-dependent apoptosis.
Sommerfeld A, Reinehr R, Haussinger D
J Biol Chem. 2014; 290(7):4398-409.
PMID: 25548285
PMC: 4326845.
DOI: 10.1074/jbc.M114.617035.
SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis.
Zhu Y, Yan Y, Principe D, Zou X, Vassilopoulos A, Gius D
Cancer Metab. 2014; 2:15.
PMID: 25332769
PMC: 4203689.
DOI: 10.1186/2049-3002-2-15.
Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours.
Baro M, de Llobet L, Figueras A, Skvortsova I, Mesia R, Balart J
Br J Cancer. 2014; 111(7):1310-8.
PMID: 25077442
PMC: 4183853.
DOI: 10.1038/bjc.2014.432.
Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5).
Reddy M, Akula B, Cosenza S, Athuluridivakar S, Mallireddigari M, Pallela V
J Med Chem. 2014; 57(3):578-99.
PMID: 24417566
PMC: 3983396.
DOI: 10.1021/jm401073p.
Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis.
Tao R, Vassilopoulos A, Parisiadou L, Yan Y, Gius D
Antioxid Redox Signal. 2013; 20(10):1646-54.
PMID: 23886445
PMC: 3942696.
DOI: 10.1089/ars.2013.5482.
CDK4: A Key Player in the Cell Cycle, Development, and Cancer.
Baker S, Reddy E
Genes Cancer. 2013; 3(11-12):658-69.
PMID: 23634254
PMC: 3636745.
DOI: 10.1177/1947601913478972.
